In the past three decades, an increasingly globalized medical marketplace has helped improve patient access to new medicines. Sadly, it has also provided an opportunity for more substandard, adulterated, and counterfeit medical products.

While there are many pharmacopeias in the world, the goal of pharmacopeial harmonization is to achieve uniform public standards, which are truly representative of the global supply chain.

Twice a year, USP, the Japanese Pharmacopoeia, and the European Pharmacopoeia convene to carry out the harmonization activities of the Pharmacopeial Discussion Group. Review highlights from the latest meetings.